ESC Premium Access

Potential real-world benefits of low-dose rivaroxaban in Chinese stable cardiovascular patients

Congress Session

About the speaker

Professor Bryan Ping Yen Yan

The Chinese University of Hong Kong, Hong Kong (Hong Kong)
0 follower

7 more presentations in this session

Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.

Speaker: Mr A. Capiau (Ghent, BE)

Thumbnail

Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: a prospective cohort study.

Speaker: Doctor M. Vedovati (Perugia, IT)

Thumbnail

Risk of arterial calcification by conventional vitamin K antagonist treatment

Speaker: Doctor S. Hasific (Odense, DK)

Thumbnail

Efficacy and safety of uninterrupted periprocedural edoxaban in patients undergoing catheter ablation for atrial fibrillation: Prospective KYU-RABLE study

Speaker: Professor N. Takahashi (Oita, JP)

Thumbnail

Real world persistence with direct oral anticoagulants in anticoagulation naive patients with atrial fibrillation

Speaker: Doctor G. Denas (Padua, IT)

Thumbnail

Access the full session

Perspectives on anticoagulation across cardiovascular disease

Speakers: Professor B. Yan, Mr A. Capiau, Doctor M. Vedovati, Doctor S. Hasific, Professor N. Takahashi...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk